Stem cells derived from different types of fat express different cell-surface markers

June 18, 2014
Stem cells derived from different types of fat express different cell-surface markers
Stem cells derived from distinct sources of fat display different cell-surface markers — with implications for their roles in metabolism and disease. Credit: Ugreen/iStock/Thinkstock

Mesenchymal stem cells (MSCs) have a natural ability to differentiate into various cell types, such as muscle, cartilage and bone. They can be classified according to their source and include adipose-derived stem cells (ASCs) and bone marrow-derived stem cells (BMSCs). ASCs, in particular, hold tremendous potential for tissue engineering and regenerative medicine because of their relatively high abundance and ease of isolation.

Shigeki Sugii at the A*STAR Singapore Bioimaging Consortium and co-workers have now isolated ASCs from two different sources of fat: subcutaneous fat found underneath the skin and from inside the abdominal cavity. The team showed that ASCs derived from subcutaneous fat express cell-surface markers that differ from those derived from visceral fat. The finding has implications for determining the origins of ASCs and the roles of their different subtypes in metabolism-related conditions, such as obesity, and diseases such as soft tissue tumors.

Stem cells, like all other cells, express molecules at their surface that are recognized by the body's immune system. Like a fingerprint, the expression profile of these cell-surface markers is unique to each stem cell type. Scientists already know that MSCs express the cell-surface markers CD73, CD90 and CD105 but not CD14, CD19, CD34 and CD45. Recent studies have also shown that while ASCs express CD36 but not CD106, the opposite is true for BMSCs. Thus, MSCs derived from different tissues express different cell-surface markers, providing a valuable tool for determining the origins of MSCs.

Sugii and co-workers therefore proposed that ASCs derived from different types of fat may also express different cell-surface markers. To investigate this, they extracted subcutaneous and visceral fat from 12 obese patients, as well as normal and obese mice. After isolating ASCs from the fat, the team analyzed the expression profiles of over 240 cell surface markers for each sample. Their analysis revealed a high level of CD10 expression in ASCs derived from subcutaneous fat compared to ASCs derived from visceral fat. In addition, they detected a high level of CD200 expression in ASCs derived from visceral fat compared to those derived from subcutaneous fat.

The researchers also discovered that while CD10-rich ASCs from differentiate better than their CD10-deficient counterparts, CD200-deficient ASCs from visceral fat differentiate better than their CD200-rich counterparts.

"Our results suggest that CD10 and CD200 are markers of high and low adipogenic capacities," says Sugii. "Therefore CD10 and CD200 are biomarkers as well as indicators of adipogenic potentials for use in high-throughput drug-screening systems."

Explore further: Researchers distinguish subcutaneous from visceral fat stem cells using specific cell markers

More information: Ong, W. K., Tan, C. S., Chan, K. L., Goesantoso, G. G., Chan, X. H. D. et al. "Identification of specific cell-surface markers of adipose-derived stem cells from subcutaneous and visceral fat depots." Stem Cell Reports 2, 172–179 (2014). dx.doi.org/10.1016/j.stemcr.2014.01.002

Related Stories

Researchers distinguish subcutaneous from visceral fat stem cells using specific cell markers

February 20, 2014
Scientists from A*STAR's Singapore Bioimaging Consortium (SBIC) led in the discovery that two little-known fat cell markers have huge potential to assist researchers to further their understanding of fats. The discovery was ...

Stem cell source an important factor, impacting ability to treat myocardial infarction

February 13, 2013
When a research team from Denmark and Sweden compared the therapeutic capabilities of adipose-derived stem cells (ASCs) versus bone marrow-derived stem cells (BMSCs) obtained from a single 84 year-old male donor with ischemic ...

Repairing cartilage with fat: Problems and potential solutions

August 24, 2012
Stem cells isolated from fat are being considered as an option for treating tissue damage and diseases because of their accessibility and lack of rejection. New research published in BioMed Central's open access journal Stem ...

Surgeries shorter in outpatient surgery centers

May 23, 2014
(HealthDay)—Outpatient surgeries take less time when performed in ambulatory surgery centers (ASCs) compared to hospitals, according to research published in the May issue of Health Affairs.

A stem cell target for expanding waistlines?

June 16, 2011
Researchers may have found the key to developing a method to rid the body of stem cells responsible for driving fat expansion. According to a report in the June 16 Cell Stem Cell, a Cell Press publication, they've landed ...

Decrease in fat cell volume improves insulin sensitivity

May 13, 2014
(HealthDay)—For obese women, a reduction in fat cell volume after bariatric surgery is strongly associated with improvement in insulin sensitivity, with the peak incidence seen among older women, according to a study published ...

Recommended for you

Scientists find RNA with special role in nerve healing process

August 22, 2017
Scientists may have identified a new opening to intervene in the process of healing peripheral nerve damage with the discovery that an "anti-sense" RNA (AS-RNA) is expressed when nerves are injured. Their experiments in mice ...

Mouse model of human immune system inadequate for stem cell studies

August 22, 2017
A type of mouse widely used to assess how the human immune system responds to transplanted stem cells does not reflect what is likely to occur in patients, according to a study by researchers at the Stanford University School ...

Researchers offer new targets for drugs against fatty liver disease and liver cancer

August 22, 2017
There may no silver bullet for treating liver cancer or fatty liver disease, but knowing the right targets will help scientists develop the most effective treatments. Researchers in Sweden have just identified a number of ...

Make way for hemoglobin

August 18, 2017
Every cell in the body, whether skin or muscle or brain, starts out as a generic cell that acquires its unique characteristics after undergoing a process of specialization. Nowhere is this process more dramatic than it is ...

Bio-inspired materials give boost to regenerative medicine

August 18, 2017
What if one day, we could teach our bodies to self-heal like a lizard's tail, and make severe injury or disease no more threatening than a paper cut?

Are stem cells the link between bacteria and cancer?

August 17, 2017
Gastric carcinoma is one of the most common causes of cancer-related deaths, primarily because most patients present at an advanced stage of the disease. The main cause of this cancer is the bacterium Helicobacter pylori, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.